CLARAVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Aug 2025)
What this means for you
This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90563233
- Mark type
- Stylized text
- Filed
- 05 Mar 2021
- Published for opposition
- 02 Nov 2021
- Abandoned
- 04 Aug 2025
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
- Class 010 — Medical apparatus: Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients
- Class 042 — Scientific and technological services: Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence
- Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence
Owner
- Verici Dx Plc, Cardiff, GB
- Verici Dx Plc, Cardiff, GB
Prosecution history
- 04 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2025 — SOU EXTENSION 5 GRANTED
- 11 Dec 2024 — SOU EXTENSION 5 FILED
- 27 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2024 — SOU EXTENSION 4 GRANTED
- 13 Jun 2024 — SOU EXTENSION 4 FILED
- 12 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2023 — SOU EXTENSION 3 GRANTED
- 13 Dec 2023 — SOU EXTENSION 3 FILED
- 13 Dec 2023 — SOU TEAS EXTENSION RECEIVED